1 day NVNO Completes Application for VenoValve’s PMA, Shares Likely to GainZacks
The FDA’s approval of VenoValve’s PMA has the potential to significantly expand NVNO’s portfolio of bioprosthetic solutions.
XThe FDA’s approval of VenoValve’s PMA has the potential to significantly expand NVNO’s portfolio of bioprosthetic solutions.
X